First, the ability of PF-475 by LRRK2 inhibition for counteracting motor disabilities that characterized the primary event after mechanical trauma of SCI in association to ischemia and apoptosis process needs to be evaluated, to confirm the strong role of LRRK2 blocking in modulating pathological consequences of SCI, particularly in the early phases after trauma. Here, LRRK2 is linked to ischemia.